Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, finds a meta-analysis published in BMC Medicine.

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

Scientists found that obesity may exist in 11 biological forms, each linked to different genes and body functions.

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...

What if we could prevent people from developing obesity? The World Obesity Federation expects more than half the global ...

The MC4R agonist targets rare genetic and hypothalamic obesity, with potential as a combination or maintenance therapy for general obesity alongside GLP-1 agents.

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Polycystic ovary syndrome can be difficult to diagnose, but in some cases the disorder can help explain problems with obesity ...

Clinical trial data review on weight-loss drugs reveals weight regain patterns post-medication discontinuation, impacting weight management strategies.

Hengrui Pharma and Kailera Therapeutics have reported positive topline data from the former’s Phase III trial (HRS9531-301) ...

Kenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 ...